Effect of secretory DKK3 on circulating CD56bright natural killer cells in patients with liver cancer

被引：0
|
作者：
Liu, Da-Hua [1 ]
Wen, Gui-Min [2 ]
Song, Chang-Liang [3 ]
Xia, Pu [1 ,4 ]
机构：
[1] Jinzhou Med Univ, Biol Anthropol Inst, Coll Basic Med Sci, Jinzhou, Liaoning, Peoples R China
[2] Jinzhou Med Univ, Coll Nursing, Dept Community Nursing, Jinzhou, Liaoning, Peoples R China
[3] Ctr Hosp Handan, Dept Radiotherapy, Handan, Hebei, Peoples R China
[4] Jinzhou Med Univ, Biol Anthropol Inst, Jinzhou 121000, Liaoning, Peoples R China
来源：
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS | 2023年 / 38卷 / 02期
基金：
中国国家自然科学基金;
关键词：
Liver cancer; DKK3; NK cells; differentiation; cytotoxicity; NK CELLS; METHYLATION; EXPRESSION; MECHANISM; ALPHA;
D O I：
10.1177/03936155231169796
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
Background Liver cancer seriously threatens human health. Natural killer (NK) cells are an important part of the innate immune system and have strong anti-tumor ability. Immunotherapy based on NK cells has become a hot topic in the treatment of liver cancer. Methods In this study, we checked the serum DKK3 (sDKK3) and circulating CD56(bright) NK cells using ELISA and flow cytometry, respectively, in the blood of liver cancer patients. The effect on recombinant human DKK3 (rhDKK3) on CD56(bright) NK cells was analyzed in vitro. Results We found low levels of sDKK3 in liver cancer patients and a negative correlation between sDKK3 and circulating CD56(bright) NK cells. In addition, we found that DKK3 induced the differentiation and improved the cytotoxicity of CD56(bright) NK cells for the first time. It could be used as an agonist for NK cell-based immunotherapy. Conclusions Improving the clinical efficacy of NK cells through DKK3 will become a new strategy for cancer immunotherapy.
引用
收藏
页码：99 / 104
页数：6
相关论文
共 50 条
  • [21] Circulating CD56bright NK cells inversely correlate with survival of melanoma patients
    Kaat de Jonge
    Anna Ebering
    Sina Nassiri
    Hélène Maby-El Hajjami
    Hajer Ouertatani-Sakouhi
    Petra Baumgaertner
    Daniel E. Speiser
    Scientific Reports, 9
  • [22] CD56bright natural killer cells exhibit abnormal phenotype and function in severe aplastic anemia
    Chen, Tong
    Liu, ChunYan
    Li, LiJuan
    Liu, Hui
    Wang, Ting
    Shao, ZongHong
    Fu, Rong
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2019, 41 (03) : 353 - 363
  • [23] Cytotoxicity of Human Hepatic Intrasinusoidal CD56bright Natural Killer Cells against Hepatocellular Carcinoma Cells
    Hwang, Shin
    Han, Jaeseok
    Baek, Ji-Seok
    Tak, Eunyoung
    Song, Gi-Won
    Lee, Sung-Gyu
    Jung, Dong-Hwan
    Park, Gil-Chun
    Ahn, Chul-Soo
    Kim, Nayoung
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (07):
  • [24] Regulatory CD56bright natural killer cells expanded during cyclophosphamide therapy in multiple sclerosis
    Rinaldi, L.
    Laroni, A.
    Ratizato, F.
    Calabrese, M.
    Perini, P.
    Sanzari, M.
    Plebani, M.
    Battistin, L.
    Gallo, P.
    MULTIPLE SCLEROSIS, 2007, 13 : S35 - S35
  • [25] Increased proportion of CD56bright natural killer cells in active and inactive systemic lupus erythematosus
    Schepis, Danika
    Gunnarsson, Iva
    Eloranta, Maija-Leena
    Lampa, Jon
    Jacobson, Stefan H.
    Karre, Klas
    Berg, Louise
    IMMUNOLOGY, 2009, 126 (01) : 140 - 146
  • [26] Human natural killer cells:: A unique innate immunoregulatory role for the CD56bright subset.
    Cooper, MA
    Fehniger, TA
    Turner, SC
    Chen, KS
    Ghaheri, BA
    Carson, WE
    Caligiuri, MA
    BLOOD, 2000, 96 (11) : 39B - 39B
  • [27] The involvement of circulating CD69+ CD56bright natural killer cells in weight loss before bariatric surgery: A retrospective cohort study
    Chikuie, Emi
    Saeki, Yoshihiro
    Tanabe, Kazuaki
    Ota, Hiroshi
    Tanaka, Yuka
    Ohdan, Hideki
    MEDICINE, 2023, 102 (41) : E34999
  • [28] Natural killer cells in the synovial fluid of rheumatoid arthritis patients exhibit a CD56bright,CD94bright,CD158negative phenotype
    Pridgeon, C
    Lennon, GP
    Thompson, RN
    Christmas, SE
    Moots, RJ
    RHEUMATOLOGY, 2003, 42 (07) : 870 - 878
  • [29] Expansion of CD56Bright natural killer cells in the peripheral blood of multiple sclerosis patients treated with interferon-beta
    M. Saraste
    H. Irjala
    L. Airas
    Neurological Sciences, 2007, 28 : 121 - 126
  • [30] A human CD34(+) subset resides in lymph nodes and differentiates into CD56bright natural killer cells
    Freud, AG
    Becknell, B
    Roychowdhury, S
    Mao, HC
    Ferketich, AK
    Nuovo, GJ
    Hughes, TL
    Marburger, TB
    Sung, J
    Baiocchi, RA
    Guimond, M
    Caligiuri, MA
    IMMUNITY, 2005, 22 (03) : 295 - 304
12345